Trial Profile
Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2022
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 14 Jul 2022 Status changed from active, no longer recruiting to completed.
- 24 Apr 2009 New trial record